Top

Annals of Hematology

Published in:

01-12-2014 | Letter to the Editor

Association of growth differentiation factor 15 (GDF15) polymorphisms with serum GDF15 and ferritin levels in β-thalassemia

Authors: Rekha Athiyarath, Biju George, Vikram Mathews, Alok Srivastava, Eunice S. Edison

Published in: Annals of Hematology | Issue 12/2014

Excerpt

Dear Editor, …

Available only for authorised users

Fleming RE, Bacon BR (2005) Orchestration of iron homeostasis. N Engl J Med 352:1741–1744. doi:10.1056/NEJMp048363 PubMedCrossRef

Nicolas G, Chauvet C, Viatte L et al (2002) The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 110:1037–1044. doi:10.1172/JCI15686 PubMedCentralPubMedCrossRef

Nemeth E (2010) Hepcidin in beta-thalassemia. Ann N Y Acad Sci 1202:31–35. doi:10.1111/j.1749-6632.2010.05585.x PubMedCentralPubMedCrossRef

Tanno T, Bhanu NV, Oneal PA et al (2007) High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 13:1096–1101. doi:10.1038/nm1629 PubMedCrossRef

Lindmark F, Zheng SL, Wiklund F et al (2004) H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. J Natl Cancer Inst 96:1248–1254. doi:10.1093/jnci/djh227 PubMedCrossRef

Breit SN, Johnen H, Cook AD et al (2011) The TGF-β superfamily cytokine, MIC-1/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism. Growth Factors 29:187–195. doi:10.3109/08977194.2011.607137 PubMedCrossRef

Ho JE, Mahajan A, Chen M-H et al (2012) Clinical and genetic correlates of growth differentiation factor 15 in the community. Clin Chem 58:1582–1591. doi:10.1373/clinchem.2012.190322 PubMedCentralPubMedCrossRef

Kami M, Hamaki T, Kishi Y (2000) Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med 343:1657. doi:10.1056/NEJM200011303432217 PubMedCrossRef

Puliyel M, Sposto R, Berdoukas VA et al (2013) Ferritin trends do not predict changes in total body iron in patients with transfusional iron overload. Am J Hematol. doi:10.1002/ajh.23650 PubMed

10.

Wang X, Yang X, Sun K et al (2010) The haplotype of the growth-differentiation factor 15 gene is associated with left ventricular hypertrophy in human essential hypertension. Clin Sci 118:137–145. doi:10.1042/CS20080637 CrossRef

11.

Brown DA, Lindmark F, Stattin P et al (2009) Macrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer. Clin Cancer Res 15:6658–6664. doi:10.1158/1078-0432.CCR-08-3126 PubMedCentralPubMedCrossRef

12.

Paper: GDF15 Is not the sole negative regulator of hepcidin in hereditary xerocytosis. https://ash.confex.com/ash/2013/webprogram/Paper58144.html. Accessed 15 Feb 2014

13.

Santini V, Girelli D, Sanna A et al (2011) Hepcidin levels and their determinants in different types of myelodysplastic syndromes. PLoS ONE 6:e23109. doi:10.1371/journal.pone.0023109 PubMedCentralPubMedCrossRef

14.

Sharma V, Panigrahi I, Dutta P et al (2007) HFE mutation H63D predicts risk of iron over load in thalassemia intermedia irrespective of blood transfusions. Indian J Pathol Microbiol 50:82–85PubMed

15.

Andreani M, Radio FC, Testi M et al (2009) Association of hepcidin promoter c.-582 A > G variant and iron overload in thalassemia major. Haematologica 94:1293–1296. doi:10.3324/haematol.2009.006270 PubMedCentralPubMedCrossRef

16.

Turedi A, Oymak Y, Meşe T et al (2013) The effect of HFE polymorphisms on cardiac iron overload in patients with beta-thalassemia major. Pediatr Hematol Oncol 30:755–760. doi:10.3109/08880018.2013.825683 PubMedCrossRef

17.

Pasricha S-R, Frazer DM, Bowden DK, Anderson GJ (2013) Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with beta-thalassemia major: a longitudinal study. Blood. doi:10.1182/blood-2012-12-471441

Title: Association of growth differentiation factor 15 (GDF15) polymorphisms with serum GDF15 and ferritin levels in β-thalassemia
Authors: Rekha Athiyarath
Biju George
Vikram Mathews
Alok Srivastava
Eunice S. Edison
Publication date: 01-12-2014
Publisher: Springer Berlin Heidelberg
Published in: Annals of Hematology / Issue 12/2014
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-014-2113-1

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 12/2014

Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia

Vitamin D deficiency and its correction in children with sickle cell anaemia

Rapid and complete hematological response of refractory hairy cell leukemia to the BRAF inhibitor dabrafenib

The hepcidin gene promoter nc.-1010C > T; −582A > G haplotype modulates serum ferritin in individuals carrying the common H63D mutation in HFE gene

Burkitt-like post-transplant lymphoproliferative disorder (PTLD) presenting with breast mass in a renal transplant recipient: a report of a rare case

Sleep problems and psychological distress in family members of patients with hematological malignancies in the Japanese population

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials